The efficacy and biobehavioural basis of baclofen in the treatment of alcoholic liver disease (BacALD): Study protocol for a randomised controlled trial-Reference-Cited by-同舟云学术

The efficacy and biobehavioural basis of baclofen in the treatment of alcoholic liver disease (BacALD): Study protocol for a randomised controlled trial

Published:2013-11 Issue:2 Volume:36 Page:348-355
ISSN:1551-7144
Container-title:Contemporary Clinical Trials
language:en
Short-container-title:Contemporary Clinical Trials

Author:

Morley K.C.,Leung S.,Baillie A.,Haber P.S.

Funder

National Health and Medical Research Council

Publisher

Elsevier BV

Subject

Pharmacology (medical),General Medicine

Reference48 articles.

1. Worldwide mortality from cirrhosis: an update to 2002;Bosetti;J Hepatol,2007

2. Alcohol in the European region — consumption, harm and policies;Rehn,2001

3. The epidemiology of alcoholic liver disease;Mann;Alcohol Res Health,2003

4. European Status Report on Alcohol and Health;WHO,2010

5. Management strategies in alcoholic liver disease;Tilg;Nat Clin Pract Gastroenterol Hepatol,2007

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The neurobehavioural effects of cannabidiol in alcohol use disorder: Study protocol for a double-blind, randomised, cross over, placebo-controlled trial;Contemporary Clinical Trials Communications;2024-10

2. Hovenia dulcis: a Chinese medicine that plays an essential role in alcohol-associated liver disease;Frontiers in Pharmacology;2024-04-08

3. Hypothalamic-pituitary-adrenocortical response in alcohol-dependent patients during baclofen treatment and association with clinical outcome: Preliminary results;Alcohol;2023-11

4. Baclofen for alcohol use disorder;Cochrane Database of Systematic Reviews;2023-01-13

5. Impaired Decision-Making and Skin Conductance Responses Are Associated with Reward and Punishment Sensitivity in Individuals with Severe Alcohol Use Disorder;Neuropsychobiology;2023